AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,416,051 | +6.7% | 778,495 | +9.7% | 0.01% | 0.0% |
| Q2 2023 | $51,003,951 | +26.7% | 709,768 | +8.8% | 0.01% | +20.0% |
| Q1 2023 | $40,242,274 | +83435.3% | 652,436 | +4.5% | 0.01% | -28.6% |
| Q4 2022 | $48,174 | -99.8% | 624,589 | +11.0% | 0.01% | +75.0% |
| Q3 2022 | $25,102,000 | +23.3% | 562,589 | +5.8% | 0.00% | +33.3% |
| Q2 2022 | $20,366,000 | -8.2% | 531,752 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $22,186,000 | +15.7% | 536,024 | +5.6% | 0.00% | +50.0% |
| Q4 2021 | $19,172,000 | +18.4% | 507,485 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $16,197,000 | -50.3% | 491,430 | +1.7% | 0.00% | -50.0% |
| Q2 2021 | $32,600,000 | +22.9% | 483,250 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $26,531,000 | -23.8% | 468,587 | +9.7% | 0.00% | -33.3% |
| Q4 2020 | $34,812,000 | +17.0% | 427,301 | +2.3% | 0.01% | 0.0% |
| Q3 2020 | $29,750,000 | -15.1% | 417,556 | -2.0% | 0.01% | -14.3% |
| Q2 2020 | $35,041,000 | +44.8% | 425,889 | +3.6% | 0.01% | +16.7% |
| Q1 2020 | $24,193,000 | -68.2% | 411,250 | -44.1% | 0.01% | -25.0% |
| Q4 2019 | $76,076,000 | +993.8% | 736,042 | +114.2% | 0.01% | +300.0% |
| Q3 2019 | $6,955,000 | -11.3% | 343,636 | +12.8% | 0.00% | 0.0% |
| Q2 2019 | $7,844,000 | +239.4% | 304,637 | +87.5% | 0.00% | +100.0% |
| Q1 2019 | $2,311,000 | +336.0% | 162,454 | -13.8% | 0.00% | – |
| Q4 2018 | $530,000 | +63.1% | 188,410 | +100.0% | 0.00% | – |
| Q3 2018 | $325,000 | +8.0% | 94,205 | 0.0% | 0.00% | – |
| Q2 2018 | $301,000 | +30.9% | 94,205 | 0.0% | 0.00% | – |
| Q1 2018 | $230,000 | -56.4% | 94,205 | 0.0% | 0.00% | – |
| Q4 2017 | $527,000 | +1.0% | 94,205 | 0.0% | 0.00% | – |
| Q3 2017 | $522,000 | +30.8% | 94,205 | +29.6% | 0.00% | – |
| Q2 2017 | $399,000 | +77.3% | 72,694 | +25.8% | 0.00% | – |
| Q1 2017 | $225,000 | -36.6% | 57,803 | +9.8% | 0.00% | – |
| Q4 2016 | $355,000 | -8.3% | 52,647 | +7.2% | 0.00% | – |
| Q3 2016 | $387,000 | +6.3% | 49,130 | +1.7% | 0.00% | – |
| Q2 2016 | $364,000 | +23.0% | 48,325 | +40.2% | 0.00% | – |
| Q1 2016 | $296,000 | – | 34,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |